Citrus Sinensis ID: 010572


Local Sequence Feature Prediction

Prediction and (Method)Result
Residue Number Marker
Protein Sequence ?
Secondary Structure (PSIPRED) ?
Secondary Structure Prediction (SSPRO) ?
Coil and Loop (DISEMBL) ?
Flexible Loop (DISEMBL) ?
Low Complexity Region (SEG) ?
Disordered region (IsUnstruct) ?
Disordered Region (DISOPRED) ?
Disordered Region (DISEMBL) ?
Disordered Region (DISPRO) ?
Transmembrane Helix (TMHMM) ?
Transmembrane Helix (HMMTOP) ?
Transmembrane Helix (MEMSAT) ?
TM Helix, Signal Peptide (MEMSAT_SVM) ?
TM Helix, Signal Peptide (Phobius) ?
Signal Peptide (SignalP HMM Mode) ?
Signal Peptide (SignalP NN Mode) ?
Coiled Coils (COILS) ?
Positional Conservation ?
 
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------
MVKAPSLISLAALAVKRELLLGDDVIPYVYELPADLFDILLTCLPPLALQKLQTKMPFRDGDDCGSPDYCFENGRKRGRYGNFNTVWKKLFKTRWSGFTDQIEPVDWQQRYWEAHVQGCLDEAAELVVLPSFRGLISDINISDTILNYIGYEQQMNHLACDYSKLSYHCQQFGHYARCLRLQNALCVEETCQLLRESKLQSLVLRWIRFEEHVQALCKLLIQNSETLASLEFLHCKLSPSFVEGICRSLCSKRKRIHKIENLSIDISSFIENCPSSVVVELVSFLSSGRSLCSLKLRHCHLDRDFGRMVFSSLLEASSSLSILDLSGNSIGGWLSKYDRSGPLFSLGAGKSLQSLRLLNLSHIAASLGKFFGTSVQVLNIGAIGLGSSGFRVLQDGVTKELKLVNINISKNRGGVETAKFLSKLMPLAPELVEVNAGYNLMPLESLTIICSALKVAKGHLQRLDLTGNNWELQPSHVSMLSEFRHNGLPILILPTLQALDVPYDDEP
ccccccHHHHHHHHHHHHHcccccccHHHHcccHHHHHHHHHcccHHHHHHHHHcccccccccccccccccccccccccccccHHHHHHHHHccccccccccccccHHHHHHHHHHHHHHHHHHHHHcccccccccccccccHHHHHHHHHHHccccccccHHHHHHHHHHHccccccccccccHHHHHHHHHHHccccccHHccccccHHHHHHHHHHHHHccccccEEEcccccccHHHHHHHHHHHHccccccccccccccccccccccccHHHHHHHHHHHcccccccEEEcccccccHHHHHHHHHHHHHccccccEEEcccccccHHHHHHHHcccccccccccccHHHccccccHHHHHHHHHHcccccEEEcccccccHHHHHHHHHHHHccccccEEEcccccccHHHHHHHHHHccccccccEEEcccccccHHHHHHHHHHHccccccccEEEcccccccccHHHHHHHHHHHHccccEEEccccccccccccccc
ccccHHHHHHHHHHHHHHHHcccccccHHHHccHHHHHHHHHcccHHHHHHHHHcccccccccccccccccccccccccccccHHHHHHHHHccccccccccccccHHHHHHHHHHHHHHHHHHHHHHccccccccccEEccHHHHHHHcccccccccccccHHHHHHHHHHcHHHHHEcccccEEHHHHHHHHHHHHHHHEEEEEEccHHHHHHHHHHHHHHHHHHHHcEEEEccccHHHHHHHHHHHHHHcccccccEEEEEEccccccccccccHHHHHHHHHcccEEEEEEEccccccHHHHHHHHHHHHHccccccEEEcccccHHHHHHHcccccccHccccccccHHHHHccHHHHHHHHHHHcccccEEEEccccccccHHHHHHHHHHHHHccEEEEEccccccHHHHHHHHHHHHHHccccEEEEHHHccccHHHHHHHHHHHHHccccEEEEEccccccccccccccHHHHHHHccccEEEEcccccccccccccc
MVKAPSLISLAALAVKRELllgddvipyvyelPADLFDILLTclpplalqklqtkmpfrdgddcgspdycfengrkrgrygnfNTVWKKLFKTRwsgftdqiepvdWQQRYWEAHVQGCLDEAAElvvlpsfrglisdinisdTILNYIGYEQQMNHLacdysklsyhcqqfgHYARCLRLQNALCVEETCQLLRESKLQSLVLRWIRFEEHVQALCKLLIQNSETLASLEFLHcklspsfvEGICRSLCSKRKRIHKIENLSIDISSFIENCPSSVVVELVSFLSSGRSLCSLKLRHCHLDRDFGRMVFSSLLEASSslsildlsgnsiggwlskydrsgplfslgagkslqSLRLLNLSHIAASLGKFFGTSVQVLNIGAiglgssgfrvlqdgvtkELKLVNINIsknrggveTAKFLSklmplapelvevnagynlmplESLTIICSALKVAKGHLQrldltgnnwelqpsHVSMLSefrhnglpililptlqaldvpyddep
mvkapsliSLAALAVKRELLLGDDVIPYVYELPADLFDILLTCLPPLALQKLQTKMPFRDGDDCGSPDYCFengrkrgrygnfNTVWKKLFKTRWSGFTDQIEPVDWQQRYWEAHVQGCLDEAAELVVLPSFRGLISDINISDTILNYIGYEQQMNHLACDYSKLSYHCQQFGHYARCLRLQNALCVEETCQLLRESKLQSLVLRWIRFEEHVQALCKLLIQNSETLASLEFLHCKLSPSFVEGICRSLCSKRKRIHKIENLSIDISSFIENCPSSVVVELVSFLSSGRSLCSLKLRHCHLDRDFGRMVFSSLLEASSSLSILDLSGNSIGGWLSKYDRSGPLFSLGAGKSLQSLRLLNLSHIAASLGKFFGTSVQVLNIGAIGLGSSGFRVLQDGVTKELKLvninisknrggvetAKFLSKLMPLAPELVEVNAGYNLMPLESLTIICSALKVAKGHLQRLDLTGNNWELQPSHVSMLSEFRHNGLPILIlptlqaldvpyddep
MVKAPSLISLAALAVKRELLLGDDVIPYVYELPADLFDILLTCLPPLALQKLQTKMPFRDGDDCGSPDYCFENGRKRGRYGNFNTVWKKLFKTRWSGFTDQIEPVDWQQRYWEAHVQGCLDEAAELVVLPSFRGLISDINISDTILNYIGYEQQMNHLACDYSKLSYHCQQFGHYARCLRLQNALCVEETCQLLRESKLQSLVLRWIRFEEHVQALCKLLIQNSETLASLEFLHCKLSPSFVEGICRSLCSKRKRIHKIENLSIDISSFIENCPssvvvelvsflssGRSLCSLKLRHCHLDRDFGRMVFsslleassslsildlsgnsIGGWLSKYDRSGPLFSLGAGKSLQSLRLLNLSHIAASLGKFFGTSVQVLNIGAIGLGSSGFRVLQDGVTKELKLVNINISKNRGGVETAKFLSKLMPLAPELVEVNAGYNLMPLESLTIICSALKVAKGHLQRLDLTGNNWELQPSHVSMLSEFRHNGLPILILPTLQALDVPYDDEP
******LISLAALAVKRELLLGDDVIPYVYELPADLFDILLTCLPPLALQKLQTKMPFRDGDDCGSPDYCFENGRKRGRYGNFNTVWKKLFKTRWSGFTDQIEPVDWQQRYWEAHVQGCLDEAAELVVLPSFRGLISDINISDTILNYIGYEQQMNHLACDYSKLSYHCQQFGHYARCLRLQNALCVEETCQLLRESKLQSLVLRWIRFEEHVQALCKLLIQNSETLASLEFLHCKLSPSFVEGICRSLCSKRKRIHKIENLSIDISSFIENCPSSVVVELVSFLSSGRSLCSLKLRHCHLDRDFGRMVFSSLLEASSSLSILDLSGNSIGGWLSKYDRSGPLFSLGAGKSLQSLRLLNLSHIAASLGKFFGTSVQVLNIGAIGLGSSGFRVLQDGVTKELKLVNINISKNRGGVETAKFLSKLMPLAPELVEVNAGYNLMPLESLTIICSALKVAKGHLQRLDLTGNNWELQPSHVSMLSEFRHNGLPILILPTLQALDV******
**KAPSLISLAALAVKRELLLGDDVIPYVYELPADLFDILLTCLPPLALQKLQTKMPFRDGDDCGSPDYCFENGRKRGRYGNFNTVWKKLFKTRWSGFTDQIEPVDWQQRYWEAHVQGCLDEAAELVVLPSFRGLISDINISDTILNYIGYEQQMNHLACDYSKLSYHCQQFGHYARCLRLQNALCVEETCQLLRESKLQSLVLRWIRFEEHVQALCKLLIQNSETLASLEFLHCKLSPSFVEGICRSLCSKRKRIHKIENLSIDISSFIENCPSSVVVELVSFLSSGRSLCSLKLRHCHLDRDFGRMVFSSLLEASSSLSILDLSGNSIGGWLSKYDRSGPLFSLGAGKSLQSLRLLNLSHIAASLGKFFGTSVQVLNIGAIGLGSSGFRVLQDGVTKELKLVNINISKNRGGVETAKFLSKLMPLAPELVEVNAGYNLMPLESLTIICSALKVAKGHLQRLDLTGNNWELQPSHVSMLSEFRHNGLPILILPTLQA*********
MVKAPSLISLAALAVKRELLLGDDVIPYVYELPADLFDILLTCLPPLALQKLQTKMPFRDGDDCGSPDYCFENGRKRGRYGNFNTVWKKLFKTRWSGFTDQIEPVDWQQRYWEAHVQGCLDEAAELVVLPSFRGLISDINISDTILNYIGYEQQMNHLACDYSKLSYHCQQFGHYARCLRLQNALCVEETCQLLRESKLQSLVLRWIRFEEHVQALCKLLIQNSETLASLEFLHCKLSPSFVEGICRSLCSKRKRIHKIENLSIDISSFIENCPSSVVVELVSFLSSGRSLCSLKLRHCHLDRDFGRMVFSSLLEASSSLSILDLSGNSIGGWLSKYDRSGPLFSLGAGKSLQSLRLLNLSHIAASLGKFFGTSVQVLNIGAIGLGSSGFRVLQDGVTKELKLVNINISKNRGGVETAKFLSKLMPLAPELVEVNAGYNLMPLESLTIICSALKVAKGHLQRLDLTGNNWELQPSHVSMLSEFRHNGLPILILPTLQALDVPYDDEP
*VKAPSLISLAALAVKRELLLGDDVIPYVYELPADLFDILLTCLPPLALQKLQTKMPFRDGD****PD******R*RGRYGNFNTVWKKLFKTRWSGFTDQIEPVDWQQRYWEAHVQGCLDEAAELVVLPSFRGLISDINISDTILNYIGYEQQMNHLACDYSKLSYHCQQFGHYARCLRLQNALCVEETCQLLRESKLQSLVLRWIRFEEHVQALCKLLIQNSETLASLEFLHCKLSPSFVEGICRSLCSKRKRIHKIENLSIDISSFIENCPSSVVVELVSFLSSGRSLCSLKLRHCHLDRDFGRMVFSSLLEASSSLSILDLSGNSIGGWLSKYDRSGPLFSLGAGKSLQSLRLLNLSHIAASLGKFFGTSVQVLNIGAIGLGSSGFRVLQDGVTKELKLVNINISKNRGGVETAKFLSKLMPLAPELVEVNAGYNLMPLESLTIICSALKVAKGHLQRLDLTGNNWELQPSHVSMLSEFRHNGLPILILPTLQALD*P*****
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
SSSSSSSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
MVKAPSLISLAALAVKRELLLGDDVIPYVYELPADLFDILLTCLPPLALQKLQTKMPFRDGDDCGSPDYCFENGRKRGRYGNFNTVWKKLFKTRWSGFTDQIEPVDWQQRYWEAHVQGCLDEAAELVVLPSFRGLISDINISDTILNYIGYEQQMNHLACDYSKLSYHCQQFGHYARCLRLQNALCVEETCQLLRESKLQSLVLRWIRFEEHVQALCKLLIQNSETLASLEFLHCKLSPSFVEGICRSLCSKRKRIHKIENLSIDISSFIENCPSSVVVELVSFLSSGRSLCSLKLRHCHLDRDFGRMVFSSLLEASSSLSILDLSGNSIGGWLSKYDRSGPLFSLGAGKSLQSLRLLNLSHIAASLGKFFGTSVQVLNIGAIGLGSSGFRVLQDGVTKELKLVNINISKNRGGVETAKFLSKLMPLAPELVEVNAGYNLMPLESLTIICSALKVAKGHLQRLDLTGNNWELQPSHVSMLSEFRHNGLPILILPTLQALDVPYDDEP
no confident homologs detected

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST ?

No hits with e-value below 0.001 by BLAST

Close Homologs in the Non-Redundant Database Detected by BLAST ?

GI ?Alignment Graph ?Length ? Definition ? Q cover ? H cover ? Identity ? E-value ?
Query507
255560275598 protein binding protein, putative [Ricin 0.964 0.817 0.454 1e-117
297744269580 unnamed protein product [Vitis vinifera] 0.708 0.618 0.509 4e-98
449443929604 PREDICTED: uncharacterized protein LOC10 0.708 0.594 0.528 3e-91
356503658604 PREDICTED: uncharacterized protein LOC10 0.696 0.584 0.516 4e-91
449475557604 PREDICTED: LOW QUALITY PROTEIN: uncharac 0.708 0.594 0.528 4e-91
359480084 834 PREDICTED: uncharacterized protein LOC10 0.644 0.392 0.508 9e-89
356570694 625 PREDICTED: uncharacterized protein LOC10 0.696 0.564 0.477 5e-86
42569177604 leucine-rich repeats-ribonuclease inhibi 0.988 0.829 0.373 9e-84
297832112603 leucine-rich repeat family protein [Arab 0.785 0.660 0.489 3e-80
357154921 653 PREDICTED: uncharacterized protein LOC10 0.642 0.499 0.416 2e-59
>gi|255560275|ref|XP_002521155.1| protein binding protein, putative [Ricinus communis] gi|223539724|gb|EEF41306.1| protein binding protein, putative [Ricinus communis] Back     alignment and taxonomy information
 Score =  427 bits (1099), Expect = e-117,   Method: Compositional matrix adjust.
 Identities = 273/601 (45%), Positives = 341/601 (56%), Gaps = 112/601 (18%)

Query: 14  AVKRELLLGDDVI--PYVYELPADLFDILLTCLPPLALQKLQTKMPFRD--GDDCGSP-D 68
           A+KR+L+ GDDV+    +YE+P+ LF IL+T LPPLAL  LQ +MP+ +  G +C    D
Sbjct: 3   AIKRQLISGDDVLMLAEIYEIPSHLFSILVTKLPPLALHNLQMEMPYENSNGYECSDGGD 62

Query: 69  YCFENGRKRGRYGNFNTVWKKLFKTRWSGF--TDQIEPVDWQQRYWEAHVQGCLDEAAEL 126
            C + GRKRGR   FNT WK LFK RW     TD +E  +W Q YWE H+Q CLDEAA  
Sbjct: 63  GCSKIGRKRGRSCKFNTEWKTLFKLRWPQIVDTDSVESDNWHQAYWEKHLQNCLDEAAGS 122

Query: 127 VVLPSFRGLISDINISDTILNYIGYEQQMNHLACDYSKLSYHCQQFGHYARCLRLQNALC 186
            ++ SF G I +I + D IL +IG E  +NH    YSKLSYH QQ GHYARCLRLQN LC
Sbjct: 123 SMV-SFDGCIGEIKVPDYILKWIGCEGHLNHSI--YSKLSYHFQQLGHYARCLRLQNVLC 179

Query: 187 VEETCQLLRESKLQSLVLRWIRFEEHVQALCKLLIQNSETLASLEFLHCK---------- 236
           V ETCQLLR S+LQ+L LRWIR +EHV  LC+LLIQN ETL SLEF+HCK          
Sbjct: 180 VAETCQLLRNSQLQNLALRWIRSQEHVDGLCQLLIQNRETLTSLEFVHCKLSSTFVDAIC 239

Query: 237 ------------------------------LSPSFVEGIC--RSLCSKR-------KRIH 257
                                         L PS V  +   RSLCS R       ++  
Sbjct: 240 RSLEIKDKQTHGIKNFSIRTSIFLETDLVSLPPSLVSFLSSGRSLCSLRFSGNHLDRKFA 299

Query: 258 KI---------ENLSI-DISSFI--------ENCPSSVVVELVSFLSSGRSLCSLKLRHC 299
           +I          N+S+ D+S  I            SS+V        S +SL  L +R+ 
Sbjct: 300 RILFTLLFDDSSNISVLDLSDNIIAGWLSNFNRGSSSMVPSTFGITKSLQSLRILNVRNN 359

Query: 300 HLDR-DFGRMVFSSLLEASSSLSILDLSGNSIGG---------WLSKYDRSGPLFSLG-- 347
           +L + D   + ++ L     +L ILDL  N I           +    +R  PL  L   
Sbjct: 360 NLRKCDMKSLRYTLL--CMPNLDILDLGENPIEDEGIRCLIPYFTEAVERCSPLVELNLE 417

Query: 348 ------------------AGKSLQSLRLLNL---SHIAASLGKFFGTSVQVLNIGAIGLG 386
                               K L SL L +    S IA +LGKF  T ++ LNIG IGLG
Sbjct: 418 SCELSCEGVTLLLDTLSTLQKPLNSLTLADNGLGSPIAGALGKFLCTPIRELNIGGIGLG 477

Query: 387 SSGFRVLQDGVTKELKLVNINISKNRGGVETAKFLSKLMPLAPELVEVNAGYNLMPLESL 446
           S+GF  LQ G+ +ELKLV INISKNRGG+ETAKFL KLM LAP+LV V A YNLMP ESL
Sbjct: 478 SAGFLELQKGMMEELKLVEINISKNRGGLETAKFLLKLMSLAPDLVAVKASYNLMPAESL 537

Query: 447 TIICSALKVAKGHLQRLDLTGNNWELQPSHVSMLSEFRHNGLPILILPTLQALDVPYDDE 506
           T+ICS LK +KG+LQ LDLTGN W+ Q +H S+L++F+HNG PILIL ++ A  +PYDD+
Sbjct: 538 TLICSGLKASKGNLQHLDLTGNTWDYQQTHASVLADFQHNGRPILILSSIHAPHIPYDDD 597

Query: 507 P 507
           P
Sbjct: 598 P 598




Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Class:

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297744269|emb|CBI37239.3| unnamed protein product [Vitis vinifera] Back     alignment and taxonomy information
>gi|449443929|ref|XP_004139728.1| PREDICTED: uncharacterized protein LOC101206924 [Cucumis sativus] Back     alignment and taxonomy information
>gi|356503658|ref|XP_003520623.1| PREDICTED: uncharacterized protein LOC100794405 [Glycine max] Back     alignment and taxonomy information
>gi|449475557|ref|XP_004154489.1| PREDICTED: LOW QUALITY PROTEIN: uncharacterized protein LOC101227026 [Cucumis sativus] Back     alignment and taxonomy information
>gi|359480084|ref|XP_002267362.2| PREDICTED: uncharacterized protein LOC100261775 [Vitis vinifera] Back     alignment and taxonomy information
>gi|356570694|ref|XP_003553520.1| PREDICTED: uncharacterized protein LOC100817679 [Glycine max] Back     alignment and taxonomy information
>gi|42569177|ref|NP_179611.2| leucine-rich repeats-ribonuclease inhibitor domain-containing protein [Arabidopsis thaliana] gi|330251888|gb|AEC06982.1| leucine-rich repeats-ribonuclease inhibitor domain-containing protein [Arabidopsis thaliana] Back     alignment and taxonomy information
>gi|297832112|ref|XP_002883938.1| leucine-rich repeat family protein [Arabidopsis lyrata subsp. lyrata] gi|297329778|gb|EFH60197.1| leucine-rich repeat family protein [Arabidopsis lyrata subsp. lyrata] Back     alignment and taxonomy information
>gi|357154921|ref|XP_003576947.1| PREDICTED: uncharacterized protein LOC100822893 [Brachypodium distachyon] Back     alignment and taxonomy information

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST ?

ID ? Alignment graph ? Length ? Definition ? Q cover ? H cover ? Identity ? E-value ?
Query507
TAIR|locus:2039027604 AT2G20210 "AT2G20210" [Arabido 0.911 0.764 0.404 4.8e-78
UNIPROTKB|Q86W251043 NLRP13 "NACHT, LRR and PYD dom 0.209 0.101 0.260 0.00081
TAIR|locus:2039027 AT2G20210 "AT2G20210" [Arabidopsis thaliana (taxid:3702)] Back     alignment and assigned GO terms
 Score = 785 (281.4 bits), Expect = 4.8e-78, P = 4.8e-78
 Identities = 195/482 (40%), Positives = 257/482 (53%)

Query:     1 MVKAPSLISLAALAVKRELLLGDDVIPYVYELPADLFDILLTCLPPLALQKLQTKMPFR- 59
             M KAPSL  L   ++K +LL  D+ IP +YELP++L D ++  LP LALQK QT MPF  
Sbjct:     1 MTKAPSLAFLCIQSLKIQLLESDNPIPDLYELPSELLDGIVAHLPALALQKFQTNMPFHC 60

Query:    60 -DGDDCGSPDYCFENGRKRGRYGNFNTVWKKLFKTRWSGFTDQIE-PVDWQQRYWEAHVQ 117
              D  + G  D C   GRKR R     + WK LFK RW  F D++E P DWQQ YWE H+Q
Sbjct:    61 LDSYESGD-DCCLITGRKRARNDVLGSSWKLLFKLRWPDFVDRVESPADWQQLYWEKHLQ 119

Query:   118 GCLDEAAELVVLPSFRGLISDINISDTILNYIGYEQQ-MNHLACDYSKLSYHCQQFGHYA 176
              C+DEAAE+ + P+F G I  IN+SD IL YI +E+  M    C   +LS+H Q FG Y 
Sbjct:   120 NCVDEAAEVALRPTFSGRICSINVSDNILRYICHEEHIMTCQNCVCKELSFHFQTFGPYL 179

Query:   177 RCLRLQNALCVEETCQLLRESKLQSLVLRWIRFEEHVQALCKLLIQNSETLASLEFLHCK 236
             RCLRL N LCV ET +LLR SKL+SLVLRWIR E+HV+ LCKLLIQ+ ETL SLE +HCK
Sbjct:   180 RCLRLLNVLCVTETSELLRTSKLRSLVLRWIRSEKHVEPLCKLLIQSRETLTSLELIHCK 239

Query:   237 LSPSFVEGICRSLCSKRKRIHKIENLSIDISSFIENCPXXXXXXXXXXXXXGRSLCSLKL 296
             LS S +  IC SL  K      ++   I  SS IE  P              R+L SL  
Sbjct:   240 LSLSSISAICTSLHEKGIHTTGMQRFCIKTSS-IEIDPLAAPSAFVSFLMSVRTLHSLHF 298

Query:   297 RHCHLDRDFGRMVFXXXXXXXXXXXXXXXXXXXIGGWLSKYDRSGPLFSLGAGKSLQSLR 356
                +LDR F RMVF                   I GWLS +     + SL +GKSLQSL 
Sbjct:   299 GDSNLDRYFARMVFSTLLDSSSNLSSLDLSENNISGWLSTFSCKSVVGSLSSGKSLQSLC 358

Query:   357 LLNLS------HIAASLGK--FFGTSVQVLNIGAIGLGSSGFRVLQDGVTK--ELKLVNI 406
              LNL       + A +L         ++ L++    +  SG R L    TK  + +L ++
Sbjct:   359 KLNLRGNELDRYDAENLAHALLHMPGLESLDLSGNPIEDSGIRSLISYFTKNPDSRLADL 418

Query:   407 NISK-NRGGVETAKFLSKLMPLAPELVEVNAGYNLMPLESLTIICSALKVAKGHLQRLDL 465
             N+           +FL  L  L   L  ++   N +  E    + ++  ++   ++ L++
Sbjct:   419 NLENCELSCCGVIEFLDTLSMLEKPLKFLSVADNALGSEVAEAVVNSFTIS---IESLNI 475

Query:   466 TG 467
              G
Sbjct:   476 MG 477


GO:0016114 "terpenoid biosynthetic process" evidence=RCA
UNIPROTKB|Q86W25 NLRP13 "NACHT, LRR and PYD domains-containing protein 13" [Homo sapiens (taxid:9606)] Back     alignment and assigned GO terms

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries ?

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server ?

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software ?

No EC number assignment, probably not an enzyme!


Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING ?

Your Input:
AT2G20210
leucine-rich repeat family protein; leucine-rich repeat family protein; FUNCTIONS IN- protein binding; LOCATED IN- endomembrane system; EXPRESSED IN- 12 plant structures; EXPRESSED DURING- 4 anthesis, F mature embryo stage, petal differentiation and expansion stage, D bilateral stage, E expanded cotyledon stage; CONTAINS InterPro DOMAIN/s- Leucine-rich repeat (InterPro-IPR001611), Leucine-rich repeat, ribonuclease inhibitor subtype (InterPro-IPR003590); Has 1691 Blast hits to 1352 proteins in 107 species- Archae - 0; Bacteria - 100; Metazoa - 1035; Fungi - 8; Plants - 127; Viruses - 0; [...] (604 aa)
(Arabidopsis thaliana)
Predicted Functional Partners:
 
Sorry, there are no predicted associations at the current settings.
 

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query507
cd00116319 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo 1e-06
>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily Back     alignment and domain information
 Score = 49.7 bits (119), Expect = 1e-06
 Identities = 43/191 (22%), Positives = 73/191 (38%), Gaps = 27/191 (14%)

Query: 279 VELVSFLSSGRSLCSLKLRHCHLDRDFGRMVFSSLLEASSSLSILDLSGNSIGGWLSKYD 338
             ++  L    SL  LKL +  L     R++   L +   +L  L L  N + G      
Sbjct: 98  CGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEG------ 151

Query: 339 RSGPLFSLGAGKSLQSLRLLNLSHIAASLGKFFGTSVQVLNIGAIGLGSSGFRVLQDGVT 398
                 +L   K+L++ R L                 + LN+   G+G +G R L +G+ 
Sbjct: 152 --ASCEALA--KALRANRDL-----------------KELNLANNGIGDAGIRALAEGLK 190

Query: 399 KELKLVNINISKNRGGVETAKFLSKLMPLAPELVEVNAGYNLMPLESLTIICSALKVAKG 458
               L  ++++ N    E A  L++ +     L  +N G N +       + SAL     
Sbjct: 191 ANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNI 250

Query: 459 HLQRLDLTGNN 469
            L  L L+ N+
Sbjct: 251 SLLTLSLSCND 261


LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

Conserved Domains Detected by HHsearch ?

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query 507
KOG1909382 consensus Ran GTPase-activating protein [RNA proce 99.85
KOG1909382 consensus Ran GTPase-activating protein [RNA proce 99.85
cd00116319 LRR_RI Leucine-rich repeats (LRRs), ribonuclease i 99.85
cd00116319 LRR_RI Leucine-rich repeats (LRRs), ribonuclease i 99.84
PLN00113 968 leucine-rich repeat receptor-like protein kinase; 99.71
COG5238388 RNA1 Ran GTPase-activating protein (RanGAP) involv 99.56
KOG4308478 consensus LRR-containing protein [Function unknown 99.54
KOG4308 478 consensus LRR-containing protein [Function unknown 99.5
PLN00113 968 leucine-rich repeat receptor-like protein kinase; 99.46
KOG4194 873 consensus Membrane glycoprotein LIG-1 [Signal tran 99.2
KOG4194 873 consensus Membrane glycoprotein LIG-1 [Signal tran 99.19
COG5238 388 RNA1 Ran GTPase-activating protein (RanGAP) involv 99.19
KOG0444 1255 consensus Cytoskeletal regulator Flightless-I (con 98.97
KOG0618 1081 consensus Serine/threonine phosphatase 2C containi 98.68
PRK15370 754 E3 ubiquitin-protein ligase SlrP; Provisional 98.66
PRK15387 788 E3 ubiquitin-protein ligase SspH2; Provisional 98.65
KOG2120419 consensus SCF ubiquitin ligase, Skp2 component [Po 98.64
PRK15387 788 E3 ubiquitin-protein ligase SspH2; Provisional 98.63
KOG0444 1255 consensus Cytoskeletal regulator Flightless-I (con 98.58
KOG3207505 consensus Beta-tubulin folding cofactor E [Posttra 98.56
PRK15370 754 E3 ubiquitin-protein ligase SlrP; Provisional 98.55
KOG0618 1081 consensus Serine/threonine phosphatase 2C containi 98.54
KOG2120419 consensus SCF ubiquitin ligase, Skp2 component [Po 98.34
KOG0472 565 consensus Leucine-rich repeat protein [Function un 98.27
KOG3207505 consensus Beta-tubulin folding cofactor E [Posttra 98.25
PLN03210 1153 Resistant to P. syringae 6; Provisional 98.14
PLN03210 1153 Resistant to P. syringae 6; Provisional 98.1
KOG1259490 consensus Nischarin, modulator of integrin alpha5 98.03
PF14580175 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ 97.97
PF14580175 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ 97.91
KOG4237 498 consensus Extracellular matrix protein slit, conta 97.89
KOG0472 565 consensus Leucine-rich repeat protein [Function un 97.69
KOG4341483 consensus F-box protein containing LRR [General fu 97.64
smart0036828 LRR_RI Leucine rich repeat, ribonuclease inhibitor 97.53
KOG4237 498 consensus Extracellular matrix protein slit, conta 97.51
KOG0617264 consensus Ras suppressor protein (contains leucine 97.47
KOG1859 1096 consensus Leucine-rich repeat proteins [General fu 97.44
PLN03150623 hypothetical protein; Provisional 97.36
KOG1259490 consensus Nischarin, modulator of integrin alpha5 97.26
KOG0617264 consensus Ras suppressor protein (contains leucine 97.24
KOG4242553 consensus Predicted myosin-I-binding protein [Cell 97.2
smart0036828 LRR_RI Leucine rich repeat, ribonuclease inhibitor 97.2
KOG4341483 consensus F-box protein containing LRR [General fu 97.16
PLN03150623 hypothetical protein; Provisional 97.13
PF1385561 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF 97.07
KOG3665 699 consensus ZYG-1-like serine/threonine protein kina 96.97
KOG2982418 consensus Uncharacterized conserved protein [Funct 96.77
COG4886394 Leucine-rich repeat (LRR) protein [Function unknow 96.61
COG4886394 Leucine-rich repeat (LRR) protein [Function unknow 96.6
KOG4242553 consensus Predicted myosin-I-binding protein [Cell 96.44
KOG3735353 consensus Tropomodulin and leiomodulin [Cytoskelet 96.36
PF1385561 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF 96.34
KOG1859 1096 consensus Leucine-rich repeat proteins [General fu 96.33
KOG1947482 consensus Leucine rich repeat proteins, some prote 96.31
PF1279944 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ 96.2
PF1351624 LRR_6: Leucine Rich repeat; PDB: 3RGZ_A 3RJ0_A 3RI 96.16
KOG3665 699 consensus ZYG-1-like serine/threonine protein kina 96.08
KOG0531414 consensus Protein phosphatase 1, regulatory subuni 95.82
PF1351624 LRR_6: Leucine Rich repeat; PDB: 3RGZ_A 3RJ0_A 3RI 95.81
PF1279944 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ 95.79
KOG0531414 consensus Protein phosphatase 1, regulatory subuni 95.59
KOG1947 482 consensus Leucine rich repeat proteins, some prote 95.55
KOG2982 418 consensus Uncharacterized conserved protein [Funct 95.09
KOG4579177 consensus Leucine-rich repeat (LRR) protein associ 94.82
KOG0532 722 consensus Leucine-rich repeat (LRR) protein, conta 94.52
KOG3735353 consensus Tropomodulin and leiomodulin [Cytoskelet 94.24
KOG0532 722 consensus Leucine-rich repeat (LRR) protein, conta 92.4
PF06881109 Elongin_A: RNA polymerase II transcription factor 92.27
KOG4579177 consensus Leucine-rich repeat (LRR) protein associ 91.84
KOG3926332 consensus F-box proteins [Amino acid transport and 91.77
KOG2123 388 consensus Uncharacterized conserved protein [Funct 91.67
KOG4658889 consensus Apoptotic ATPase [Signal transduction me 91.46
KOG2739260 consensus Leucine-rich acidic nuclear protein [Cel 90.05
PRK15386 426 type III secretion protein GogB; Provisional 87.56
PF0826343 LRRNT_2: Leucine rich repeat N-terminal domain; In 86.57
smart0036726 LRR_CC Leucine-rich repeat - CC (cysteine-containi 86.03
KOG1644233 consensus U2-associated snRNP A' protein [RNA proc 85.81
KOG1644233 consensus U2-associated snRNP A' protein [RNA proc 84.32
smart0036726 LRR_CC Leucine-rich repeat - CC (cysteine-containi 83.64
KOG2739260 consensus Leucine-rich acidic nuclear protein [Cel 83.26
KOG3864221 consensus Uncharacterized conserved protein [Funct 83.23
PRK15386 426 type III secretion protein GogB; Provisional 82.39
KOG3864221 consensus Uncharacterized conserved protein [Funct 82.29
PF1350417 LRR_7: Leucine rich repeat; PDB: 3OJA_B 3G06_A 1OO 82.2
>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] Back     alignment and domain information
Probab=99.85  E-value=7.5e-21  Score=190.20  Aligned_cols=263  Identities=18%  Similarity=0.192  Sum_probs=135.3

Q ss_pred             HHHHHHHhhCCCCccEEEeecCCCChhHHHHHHHHhccCCcccccccceeccccccccCCCCcchHH---HHHHHhCCCC
Q 010572          214 QALCKLLIQNSETLASLEFLHCKLSPSFVEGICRSLCSKRKRIHKIENLSIDISSFIENCPSSVVVE---LVSFLSSGRS  290 (507)
Q Consensus       214 ~~l~~~L~~~~~~L~~LdLs~~~ls~~~~~~L~~~L~~~~~~~~~l~~L~l~~~~~le~~~~~l~~~---L~~~L~~~~s  290 (507)
                      +.+.+.+ ....++++++|++|.|+.++++.++..|++.+    .+..-.++. -|+.--...++..   +.++|..++.
T Consensus        20 ~~v~~~~-~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~----~L~~v~~sd-~ftGR~~~Ei~e~L~~l~~aL~~~~~   93 (382)
T KOG1909|consen   20 KDVEEEL-EPMDSLTKLDLSGNTFGTEAARAIAKVLASKK----ELREVNLSD-MFTGRLKDEIPEALKMLSKALLGCPK   93 (382)
T ss_pred             hhHHHHh-cccCceEEEeccCCchhHHHHHHHHHHHhhcc----cceeeehHh-hhcCCcHHHHHHHHHHHHHHHhcCCc
Confidence            3334433 34467777777777777777777777766542    122211111 1111111112221   4556666777


Q ss_pred             CCEEEccCCCCCchHHHHHHHHhccCCCCccEEECcCCCCCCcccc-c-----ccCCchhhcccCCCcCccccccch---
Q 010572          291 LCSLKLRHCHLDRDFGRMVFSSLLEASSSLSILDLSGNSIGGWLSK-Y-----DRSGPLFSLGAGKSLQSLRLLNLS---  361 (507)
Q Consensus       291 L~~L~LS~N~L~~~g~~~L~~~L~~~~~~L~~LdLS~N~L~~~l~~-~-----~~~~l~~~L~~~~~L~~L~ll~l~---  361 (507)
                      |++||||+|.++..|++.+..-+ .+...|+.|.|.+|+++..... +     .+- .....++-..|+.+...+|+   
T Consensus        94 L~~ldLSDNA~G~~g~~~l~~ll-~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~-~~kk~~~~~~Lrv~i~~rNrlen  171 (382)
T KOG1909|consen   94 LQKLDLSDNAFGPKGIRGLEELL-SSCTDLEELYLNNCGLGPEAGGRLGRALFELA-VNKKAASKPKLRVFICGRNRLEN  171 (382)
T ss_pred             eeEeeccccccCccchHHHHHHH-HhccCHHHHhhhcCCCChhHHHHHHHHHHHHH-HHhccCCCcceEEEEeecccccc
Confidence            77777777777777777665544 3457777777777777721110 0     000 00012223334444444444   


Q ss_pred             hHHHHHHhhhc--CCCcEEEeccCCCCchhHHHHHHhhcCCCCCCEEeccCCCCChHHHHHHHhhCCCCCCccEEEccCC
Q 010572          362 HIAASLGKFFG--TSVQVLNIGAIGLGSSGFRVLQDGVTKELKLVNINISKNRGGVETAKFLSKLMPLAPELVEVNAGYN  439 (507)
Q Consensus       362 ~~~~~L~~~l~--~~L~~L~Ls~n~l~~~G~~~L~~aL~~n~~L~~LdLs~N~i~~~g~~~L~~~L~~n~~L~~L~Ls~N  439 (507)
                      .++.+++..++  .+|+++.++.|+|.+.|...++.++..+++|++|||.+|.++.+|...|+.+++..+.|++|+++++
T Consensus       172 ~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dc  251 (382)
T KOG1909|consen  172 GGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDC  251 (382)
T ss_pred             ccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeeccccc
Confidence            34444444444  3555555555555555555555555555555555555555555555555555555555555555555


Q ss_pred             CCChhHHHHHHHHHhcCCCCccEEEecCCCCCCCccHHHHHHHHHHc
Q 010572          440 LMPLESLTIICSALKVAKGHLQRLDLTGNNWELQPSHVSMLSEFRHN  486 (507)
Q Consensus       440 ~l~~~g~~~L~~aL~~~~~~L~~LdL~~N~~~~~~~~~~~l~~~~~~  486 (507)
                      .+.++|+..+.+|++...++|+.|+|.+|.  |+.+++..++.....
T Consensus       252 ll~~~Ga~a~~~al~~~~p~L~vl~l~gNe--It~da~~~la~~~~e  296 (382)
T KOG1909|consen  252 LLENEGAIAFVDALKESAPSLEVLELAGNE--ITRDAALALAACMAE  296 (382)
T ss_pred             ccccccHHHHHHHHhccCCCCceeccCcch--hHHHHHHHHHHHHhc
Confidence            555555555555555444455555555554  244444444433333



>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] Back     alignment and domain information
>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily Back     alignment and domain information
>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily Back     alignment and domain information
>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional Back     alignment and domain information
>COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] Back     alignment and domain information
>KOG4308 consensus LRR-containing protein [Function unknown] Back     alignment and domain information
>KOG4308 consensus LRR-containing protein [Function unknown] Back     alignment and domain information
>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional Back     alignment and domain information
>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] Back     alignment and domain information
>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] Back     alignment and domain information
>COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] Back     alignment and domain information
>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] Back     alignment and domain information
>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] Back     alignment and domain information
>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional Back     alignment and domain information
>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional Back     alignment and domain information
>KOG2120 consensus SCF ubiquitin ligase, Skp2 component [Posttranslational modification, protein turnover, chaperones] Back     alignment and domain information
>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional Back     alignment and domain information
>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] Back     alignment and domain information
>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] Back     alignment and domain information
>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional Back     alignment and domain information
>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] Back     alignment and domain information
>KOG2120 consensus SCF ubiquitin ligase, Skp2 component [Posttranslational modification, protein turnover, chaperones] Back     alignment and domain information
>KOG0472 consensus Leucine-rich repeat protein [Function unknown] Back     alignment and domain information
>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] Back     alignment and domain information
>PLN03210 Resistant to P Back     alignment and domain information
>PLN03210 Resistant to P Back     alignment and domain information
>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] Back     alignment and domain information
>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A Back     alignment and domain information
>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A Back     alignment and domain information
>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] Back     alignment and domain information
>KOG0472 consensus Leucine-rich repeat protein [Function unknown] Back     alignment and domain information
>KOG4341 consensus F-box protein containing LRR [General function prediction only] Back     alignment and domain information
>smart00368 LRR_RI Leucine rich repeat, ribonuclease inhibitor type Back     alignment and domain information
>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] Back     alignment and domain information
>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] Back     alignment and domain information
>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] Back     alignment and domain information
>PLN03150 hypothetical protein; Provisional Back     alignment and domain information
>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] Back     alignment and domain information
>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] Back     alignment and domain information
>KOG4242 consensus Predicted myosin-I-binding protein [Cell motility] Back     alignment and domain information
>smart00368 LRR_RI Leucine rich repeat, ribonuclease inhibitor type Back     alignment and domain information
>KOG4341 consensus F-box protein containing LRR [General function prediction only] Back     alignment and domain information
>PLN03150 hypothetical protein; Provisional Back     alignment and domain information
>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A Back     alignment and domain information
>KOG3665 consensus ZYG-1-like serine/threonine protein kinases [General function prediction only] Back     alignment and domain information
>KOG2982 consensus Uncharacterized conserved protein [Function unknown] Back     alignment and domain information
>COG4886 Leucine-rich repeat (LRR) protein [Function unknown] Back     alignment and domain information
>COG4886 Leucine-rich repeat (LRR) protein [Function unknown] Back     alignment and domain information
>KOG4242 consensus Predicted myosin-I-binding protein [Cell motility] Back     alignment and domain information
>KOG3735 consensus Tropomodulin and leiomodulin [Cytoskeleton] Back     alignment and domain information
>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A Back     alignment and domain information
>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] Back     alignment and domain information
>KOG1947 consensus Leucine rich repeat proteins, some proteins contain F-box [General function prediction only] Back     alignment and domain information
>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B Back     alignment and domain information
>PF13516 LRR_6: Leucine Rich repeat; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1DFJ_I 2BNH_A 3VQ1_A 3VQ2_A 2Z64_A 2OMX_A Back     alignment and domain information
>KOG3665 consensus ZYG-1-like serine/threonine protein kinases [General function prediction only] Back     alignment and domain information
>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] Back     alignment and domain information
>PF13516 LRR_6: Leucine Rich repeat; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1DFJ_I 2BNH_A 3VQ1_A 3VQ2_A 2Z64_A 2OMX_A Back     alignment and domain information
>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B Back     alignment and domain information
>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] Back     alignment and domain information
>KOG1947 consensus Leucine rich repeat proteins, some proteins contain F-box [General function prediction only] Back     alignment and domain information
>KOG2982 consensus Uncharacterized conserved protein [Function unknown] Back     alignment and domain information
>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] Back     alignment and domain information
>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] Back     alignment and domain information
>KOG3735 consensus Tropomodulin and leiomodulin [Cytoskeleton] Back     alignment and domain information
>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] Back     alignment and domain information
>PF06881 Elongin_A: RNA polymerase II transcription factor SIII (Elongin) subunit A; InterPro: IPR010684 This family represents a conserved region within RNA polymerase II transcription factor SIII (Elongin) subunit A Back     alignment and domain information
>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] Back     alignment and domain information
>KOG3926 consensus F-box proteins [Amino acid transport and metabolism] Back     alignment and domain information
>KOG2123 consensus Uncharacterized conserved protein [Function unknown] Back     alignment and domain information
>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] Back     alignment and domain information
>KOG2739 consensus Leucine-rich acidic nuclear protein [Cell cycle control, cell division, chromosome partitioning; General function prediction only] Back     alignment and domain information
>PRK15386 type III secretion protein GogB; Provisional Back     alignment and domain information
>PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] Back     alignment and domain information
>smart00367 LRR_CC Leucine-rich repeat - CC (cysteine-containing) subfamily Back     alignment and domain information
>KOG1644 consensus U2-associated snRNP A' protein [RNA processing and modification] Back     alignment and domain information
>KOG1644 consensus U2-associated snRNP A' protein [RNA processing and modification] Back     alignment and domain information
>smart00367 LRR_CC Leucine-rich repeat - CC (cysteine-containing) subfamily Back     alignment and domain information
>KOG2739 consensus Leucine-rich acidic nuclear protein [Cell cycle control, cell division, chromosome partitioning; General function prediction only] Back     alignment and domain information
>KOG3864 consensus Uncharacterized conserved protein [Function unknown] Back     alignment and domain information
>PRK15386 type III secretion protein GogB; Provisional Back     alignment and domain information
>KOG3864 consensus Uncharacterized conserved protein [Function unknown] Back     alignment and domain information
>PF13504 LRR_7: Leucine rich repeat; PDB: 3OJA_B 3G06_A 1OOK_G 1QYY_G 1SQ0_B 1P9A_G 1GWB_A 1P8V_A 1M0Z_A 1U0N_D Back     alignment and domain information

Homologous Structure Templates

Structure Templates Detected by BLAST ?

No homologous structure with e-value below 0.005

Structure Templates Detected by RPS-BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query507
3goz_A362 Leucine-rich repeat-containing protein; LEGL7, NES 4e-19
3goz_A362 Leucine-rich repeat-containing protein; LEGL7, NES 3e-14
1z7x_W461 Ribonuclease inhibitor; leucine-rich repeat, enzym 2e-18
1z7x_W461 Ribonuclease inhibitor; leucine-rich repeat, enzym 2e-18
1z7x_W 461 Ribonuclease inhibitor; leucine-rich repeat, enzym 4e-14
1z7x_W 461 Ribonuclease inhibitor; leucine-rich repeat, enzym 8e-10
1z7x_W461 Ribonuclease inhibitor; leucine-rich repeat, enzym 9e-06
2ca6_A386 RAN GTPase-activating protein 1; GAP, GTPase activ 4e-17
2ca6_A386 RAN GTPase-activating protein 1; GAP, GTPase activ 3e-12
2ca6_A 386 RAN GTPase-activating protein 1; GAP, GTPase activ 4e-05
2ca6_A386 RAN GTPase-activating protein 1; GAP, GTPase activ 1e-04
3un9_A372 NLR family member X1; leucine rich repeat (LRR), a 2e-10
1vt4_I 1221 APAF-1 related killer DARK; drosophila apoptosome, 1e-07
1vt4_I 1221 APAF-1 related killer DARK; drosophila apoptosome, 4e-07
1vt4_I 1221 APAF-1 related killer DARK; drosophila apoptosome, 9e-07
1vt4_I 1221 APAF-1 related killer DARK; drosophila apoptosome, 2e-04
3fxi_A605 TLR4, htoll, TOLL-like receptor 4; leucine rich re 2e-05
3j0a_A 844 TOLL-like receptor 5; membrane protein, leucine-ri 4e-05
2z81_A549 CD282 antigen, TOLL-like receptor 2, variable lymp 5e-05
3vq2_A 606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 9e-05
3vq2_A606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 1e-04
1ziw_A680 TOLL-like receptor 3; innate immunity, immune syst 2e-04
1wwl_A312 Monocyte differentiation antigen CD14; LPS, immune 3e-04
3t6q_A606 CD180 antigen; protein-protein complex, leucine ri 6e-04
>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 Back     alignment and structure
 Score = 87.8 bits (218), Expect = 4e-19
 Identities = 57/324 (17%), Positives = 104/324 (32%), Gaps = 40/324 (12%)

Query: 181 LQNALCVEETCQLLRE-----SKLQSLVLRWIRF-EEHVQALCKLLIQNSETLASLEFLH 234
           +   L +      + E       + SL L            L +       ++ SL    
Sbjct: 1   MNYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSG 60

Query: 235 CKLSPSFVEGICRSLCSKRKRIHKIENLSIDISSFIENCPSSV-VVELVSFLSSG-RSLC 292
             L     + + + L +    +  + NLS        N  S     ELV  L++   ++ 
Sbjct: 61  NSLGFKNSDELVQILAAIPANVTSL-NLS-------GNFLSYKSSDELVKTLAAIPFTIT 112

Query: 293 SLKLRHCHLDRDFGRMVFSSLLEASSSLSILDLSGNSIGGWLSKYDRSGPLFSLGAGKSL 352
            L L               +     +S++ L+L GN +G       +S            
Sbjct: 113 VLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLG------IKSSDELIQILAAIP 166

Query: 353 QSLRLLNLS----------HIAASLGKFFGTSVQVLNIGAIGLGSSGFRVLQDGVTK-EL 401
            ++  LNL            +A  L      SV  L++ A  LG   +  L    +    
Sbjct: 167 ANVNSLNLRGNNLASKNCAELAKFL-ASIPASVTSLDLSANLLGLKSYAELAYIFSSIPN 225

Query: 402 KLVNINISKNRGGVETAKFLSKLMPLAPELVEVNAGYNLMP---LESLTIICSALKVAKG 458
            +V++N+  N     + + L  L      L  V   Y+++     E    + +A    + 
Sbjct: 226 HVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQ- 284

Query: 459 HLQRLDLTGNNWELQPSHVSMLSE 482
            +  +D  G   E+ PSH   +S 
Sbjct: 285 KIILVDKNGK--EIHPSHSIPISN 306


>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 Back     alignment and structure
>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 Back     alignment and structure
>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 Back     alignment and structure
>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 Back     alignment and structure
>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 Back     alignment and structure
>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 Back     alignment and structure
>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 Back     alignment and structure
>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 Back     alignment and structure
>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 Back     alignment and structure
>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 Back     alignment and structure
>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 Back     alignment and structure
>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 Back     alignment and structure
>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 Back     alignment and structure
>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 Back     alignment and structure
>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 Back     alignment and structure
>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 Back     alignment and structure
>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 Back     alignment and structure

Structure Templates Detected by HHsearch ?

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query507
1z7x_W461 Ribonuclease inhibitor; leucine-rich repeat, enzym 99.93
1z7x_W461 Ribonuclease inhibitor; leucine-rich repeat, enzym 99.92
2ca6_A386 RAN GTPase-activating protein 1; GAP, GTPase activ 99.92
3goz_A362 Leucine-rich repeat-containing protein; LEGL7, NES 99.91
3goz_A362 Leucine-rich repeat-containing protein; LEGL7, NES 99.91
2ca6_A386 RAN GTPase-activating protein 1; GAP, GTPase activ 99.9
3un9_A372 NLR family member X1; leucine rich repeat (LRR), a 99.9
3un9_A372 NLR family member X1; leucine rich repeat (LRR), a 99.84
1io0_A185 Tropomodulin; LRR protein, right-handed super-heli 99.83
1pgv_A197 TMD-1, tropomodulin TMD-1; structural genomics, PS 99.8
1io0_A185 Tropomodulin; LRR protein, right-handed super-heli 99.79
1pgv_A197 TMD-1, tropomodulin TMD-1; structural genomics, PS 99.77
1ogq_A313 PGIP-2, polygalacturonase inhibiting protein; inhi 99.75
3rgz_A 768 Protein brassinosteroid insensitive 1; phytohormon 99.73
4eco_A 636 Uncharacterized protein; leucine-rich repeats, pro 99.63
4ecn_A 876 Leucine-rich repeat protein; leucine-rich repeats, 99.63
2ast_B336 S-phase kinase-associated protein 2; SCF-substrate 99.6
3v47_A455 TOLL-like receptor 5B and variable lymphocyte REC 99.59
3ogk_B592 Coronatine-insensitive protein 1; leucine rich rep 99.57
2p1m_B594 Transport inhibitor response 1 protein; F-BOX, leu 99.55
2z80_A353 TOLL-like receptor 2, variable lymphocyte recepto; 99.53
2ast_B336 S-phase kinase-associated protein 2; SCF-substrate 99.52
2z66_A306 Variable lymphocyte receptor B, TOLL-like recepto; 99.51
3ogk_B 592 Coronatine-insensitive protein 1; leucine rich rep 99.5
3v47_A 455 TOLL-like receptor 5B and variable lymphocyte REC 99.49
1ogq_A313 PGIP-2, polygalacturonase inhibiting protein; inhi 99.48
3rgz_A768 Protein brassinosteroid insensitive 1; phytohormon 99.48
2id5_A 477 Lingo-1, leucine rich repeat neuronal 6A; CNS-spec 99.47
3o6n_A390 APL1; leucine-rich repeat, protein binding; HET: N 99.46
4fmz_A347 Internalin; leucine rich repeat, structural genomi 99.46
1xku_A330 Decorin; proteoglycan, leucine-rich repeat, struct 99.46
2p1m_B594 Transport inhibitor response 1 protein; F-BOX, leu 99.44
4fmz_A347 Internalin; leucine rich repeat, structural genomi 99.44
1ozn_A285 Reticulon 4 receptor; NOGO receptor, MAD, myelinat 99.43
4fcg_A328 Uncharacterized protein; structural genomics, PSI- 99.43
2z80_A353 TOLL-like receptor 2, variable lymphocyte recepto; 99.42
1xku_A330 Decorin; proteoglycan, leucine-rich repeat, struct 99.42
3t6q_A606 CD180 antigen; protein-protein complex, leucine ri 99.41
3o53_A317 Protein LRIM1, AGAP006348-PA; leucine-rich repeat, 99.41
2z81_A 549 CD282 antigen, TOLL-like receptor 2, variable lymp 99.41
4glp_A310 Monocyte differentiation antigen CD14; alpha beta 99.4
3oja_A 487 Leucine-rich immune molecule 1; coiled-coil, helix 99.39
3vq2_A606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 99.39
2id5_A 477 Lingo-1, leucine rich repeat neuronal 6A; CNS-spec 99.37
1wwl_A312 Monocyte differentiation antigen CD14; LPS, immune 99.37
3t6q_A606 CD180 antigen; protein-protein complex, leucine ri 99.37
3zyj_A 440 Leucine-rich repeat-containing protein 4C; cell ad 99.37
3zyi_A 452 Leucine-rich repeat-containing protein 4; cell adh 99.36
3o6n_A390 APL1; leucine-rich repeat, protein binding; HET: N 99.36
2z7x_B520 TOLL-like receptor 1, variable lymphocyte recepto; 99.36
4glp_A310 Monocyte differentiation antigen CD14; alpha beta 99.36
1wwl_A312 Monocyte differentiation antigen CD14; LPS, immune 99.36
1ozn_A285 Reticulon 4 receptor; NOGO receptor, MAD, myelinat 99.35
1ziw_A 680 TOLL-like receptor 3; innate immunity, immune syst 99.35
3oja_B 597 Anopheles plasmodium-responsive leucine-rich REPE 99.35
3oja_B 597 Anopheles plasmodium-responsive leucine-rich REPE 99.35
2z7x_B520 TOLL-like receptor 1, variable lymphocyte recepto; 99.35
2ft3_A332 Biglycan; proteoglycan, dimer interface, structura 99.34
2ra8_A362 Uncharacterized protein Q64V53_bacfr; WGR domain, 99.34
2ra8_A362 Uncharacterized protein Q64V53_bacfr; WGR domain, 99.34
2z62_A276 TOLL-like receptor 4, variable lymphocyte recepto; 99.34
3o53_A317 Protein LRIM1, AGAP006348-PA; leucine-rich repeat, 99.33
2ft3_A332 Biglycan; proteoglycan, dimer interface, structura 99.33
3zyj_A 440 Leucine-rich repeat-containing protein 4C; cell ad 99.32
3zyi_A 452 Leucine-rich repeat-containing protein 4; cell adh 99.32
1o6v_A466 Internalin A; bacterial infection, extracellular r 99.32
4eco_A636 Uncharacterized protein; leucine-rich repeats, pro 99.31
2z81_A549 CD282 antigen, TOLL-like receptor 2, variable lymp 99.31
1o6v_A466 Internalin A; bacterial infection, extracellular r 99.31
1h6u_A308 Internalin H; cell adhesion, leucine rich repeat, 99.3
4ecn_A876 Leucine-rich repeat protein; leucine-rich repeats, 99.29
4fcg_A328 Uncharacterized protein; structural genomics, PSI- 99.28
3a79_B562 TLR6, VLRB.59, TOLL-like receptor 6, variable lymp 99.28
1ziw_A 680 TOLL-like receptor 3; innate immunity, immune syst 99.28
3oja_A 487 Leucine-rich immune molecule 1; coiled-coil, helix 99.25
1p9a_G290 Platelet glycoprotein IB alpha chain precursor; pl 99.25
2o6q_A270 Variable lymphocyte receptor A; leucine-rich repea 99.24
3j0a_A 844 TOLL-like receptor 5; membrane protein, leucine-ri 99.24
2z66_A306 Variable lymphocyte receptor B, TOLL-like recepto; 99.23
3bz5_A 457 Internalin-J, INLJ; leucine rich repeat (LRR), cys 99.22
3j0a_A 844 TOLL-like receptor 5; membrane protein, leucine-ri 99.21
3vq2_A606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 99.2
3a79_B562 TLR6, VLRB.59, TOLL-like receptor 6, variable lymp 99.19
2z62_A276 TOLL-like receptor 4, variable lymphocyte recepto; 99.17
1h6t_A291 Internalin B; cell adhesion, leucine rich repeat, 99.16
1h6u_A308 Internalin H; cell adhesion, leucine rich repeat, 99.16
3rfs_A272 Internalin B, repeat modules, variable lymphocyte 99.15
3m19_A251 Variable lymphocyte receptor A diversity region; a 99.14
2z63_A570 TOLL-like receptor 4, variable lymphocyte recepto; 99.14
2o6q_A270 Variable lymphocyte receptor A; leucine-rich repea 99.12
3bz5_A 457 Internalin-J, INLJ; leucine rich repeat (LRR), cys 99.11
3m19_A251 Variable lymphocyte receptor A diversity region; a 99.09
3g06_A 622 SSPH2 (leucine-rich repeat protein); E3 ubiquitin 99.08
3rfs_A272 Internalin B, repeat modules, variable lymphocyte 99.08
4ezg_A197 Putative uncharacterized protein; internalin-A, le 99.08
4ezg_A197 Putative uncharacterized protein; internalin-A, le 99.07
1m9s_A 605 Internalin B; cell invasion, GW domains, SH3 domai 99.06
1xeu_A263 Internalin C; cellular invasion, leucine-rich repe 99.04
2z63_A570 TOLL-like receptor 4, variable lymphocyte recepto; 99.01
3cvr_A 571 Invasion plasmid antigen; leucine rich repeat and 98.98
1p9a_G290 Platelet glycoprotein IB alpha chain precursor; pl 98.97
1h6t_A291 Internalin B; cell adhesion, leucine rich repeat, 98.95
1m9s_A 605 Internalin B; cell invasion, GW domains, SH3 domai 98.94
3g06_A 622 SSPH2 (leucine-rich repeat protein); E3 ubiquitin 98.91
3e6j_A229 Variable lymphocyte receptor diversity region; var 98.9
1jl5_A 454 Outer protein YOPM; leucine-rich repeat, molecular 98.89
2xwt_C239 Thyrotropin receptor; signaling protein-immune sys 98.88
1jl5_A454 Outer protein YOPM; leucine-rich repeat, molecular 98.86
1xeu_A263 Internalin C; cellular invasion, leucine-rich repe 98.86
2xot_A 361 Amphoterin-induced protein 1; cell adhesion, neuro 98.85
2o6s_A208 Variable lymphocyte receptor B; leucine-rich repea 98.84
4g8a_A635 TOLL-like receptor 4; leucine rich repeat MD-2 rel 98.83
3cvr_A 571 Invasion plasmid antigen; leucine rich repeat and 98.82
3e6j_A229 Variable lymphocyte receptor diversity region; var 98.81
4g8a_A 635 TOLL-like receptor 4; leucine rich repeat MD-2 rel 98.78
2v9t_B220 SLIT homolog 2 protein N-product; structural prote 98.77
2v9t_B220 SLIT homolog 2 protein N-product; structural prote 98.75
2v70_A220 SLIT-2, SLIT homolog 2 protein N-product; neurogen 98.74
2xwt_C239 Thyrotropin receptor; signaling protein-immune sys 98.72
2je0_A149 Acidic leucine-rich nuclear phosphoprotein 32 FAM 98.71
2v70_A220 SLIT-2, SLIT homolog 2 protein N-product; neurogen 98.71
2ell_A168 Acidic leucine-rich nuclear phosphoprotein 32 FAM 98.71
2je0_A149 Acidic leucine-rich nuclear phosphoprotein 32 FAM 98.7
1dce_A567 Protein (RAB geranylgeranyltransferase alpha subun 98.7
3e4g_A176 ATP synthase subunit S, mitochondrial; leucine-ric 98.68
2ell_A168 Acidic leucine-rich nuclear phosphoprotein 32 FAM 98.68
2xot_A361 Amphoterin-induced protein 1; cell adhesion, neuro 98.67
2o6s_A208 Variable lymphocyte receptor B; leucine-rich repea 98.63
4b8c_D 727 Glucose-repressible alcohol dehydrogenase transcr 98.61
1a9n_A176 U2A', U2A'; complex (nuclear protein/RNA), RNA, sn 98.6
1w8a_A192 SLIT protein; signaling protein, secreted protein, 98.55
2o6r_A177 Variable lymphocyte receptor B; leucine-rich repea 98.51
1dce_A567 Protein (RAB geranylgeranyltransferase alpha subun 98.5
1ds9_A198 Outer arm dynein; leucine-rich repeat, beta-BETA-a 98.49
3e4g_A176 ATP synthase subunit S, mitochondrial; leucine-ric 98.46
1w8a_A192 SLIT protein; signaling protein, secreted protein, 98.44
2wfh_A193 SLIT homolog 2 protein C-product; developmental pr 98.37
2o6r_A177 Variable lymphocyte receptor B; leucine-rich repea 98.36
1a9n_A176 U2A', U2A'; complex (nuclear protein/RNA), RNA, sn 98.34
1ds9_A198 Outer arm dynein; leucine-rich repeat, beta-BETA-a 98.32
2wfh_A193 SLIT homolog 2 protein C-product; developmental pr 98.31
4b8c_D 727 Glucose-repressible alcohol dehydrogenase transcr 98.22
3g39_A170 Variable lymphocyte receptor VLRB.2D; antibody, X- 98.14
2r9u_A174 Variable lymphocyte receptor; adaptive immunity, V 98.12
3g39_A170 Variable lymphocyte receptor VLRB.2D; antibody, X- 98.09
4ay9_X350 Follicle-stimulating hormone receptor; hormone-rec 98.06
4ay9_X350 Follicle-stimulating hormone receptor; hormone-rec 98.06
2r9u_A174 Variable lymphocyte receptor; adaptive immunity, V 97.98
3sb4_A329 Hypothetical leucine rich repeat protein; LRR, rig 97.78
2ifg_A 347 High affinity nerve growth factor receptor; TRK, T 97.44
3rw6_A267 Nuclear RNA export factor 1; retroviral constituti 97.26
2ifg_A 347 High affinity nerve growth factor receptor; TRK, T 96.96
3rw6_A267 Nuclear RNA export factor 1; retroviral constituti 96.94
3sb4_A329 Hypothetical leucine rich repeat protein; LRR, rig 95.21
4fdw_A401 Leucine rich hypothetical protein; putative cell s 94.44
4fdw_A401 Leucine rich hypothetical protein; putative cell s 92.97
4hfx_A97 Transcription elongation factor B polypeptide 3; s 84.94
2e31_A297 FBS1, F-box only protein 2; ubiquitin, SCF, ubiqui 84.01
>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Back     alignment and structure
Probab=99.93  E-value=1.5e-24  Score=228.62  Aligned_cols=274  Identities=18%  Similarity=0.146  Sum_probs=169.7

Q ss_pred             CCcCeeecccccC-hhhHHHHHHHHhhCCCCccEEEeecCCCChhHHHHHHHHhccCCcccccccceeccccccccCCCC
Q 010572          197 SKLQSLVLRWIRF-EEHVQALCKLLIQNSETLASLEFLHCKLSPSFVEGICRSLCSKRKRIHKIENLSIDISSFIENCPS  275 (507)
Q Consensus       197 ~~L~~L~Ls~~~~-~~~~~~l~~~L~~~~~~L~~LdLs~~~ls~~~~~~L~~~L~~~~~~~~~l~~L~l~~~~~le~~~~  275 (507)
                      +.|++|+++++.. ..++..+...+. .+++|++|+|++|.+++.++..++..+....   +.++.|+++.+.+.+..  
T Consensus       142 ~~L~~L~L~~n~l~~~~~~~l~~~l~-~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~---~~L~~L~L~~n~l~~~~--  215 (461)
T 1z7x_W          142 CRLEKLQLEYCSLSAASCEPLASVLR-AKPDFKELTVSNNDINEAGVRVLCQGLKDSP---CQLEALKLESCGVTSDN--  215 (461)
T ss_dssp             CCCCEEECTTSCCBGGGHHHHHHHHH-HCTTCCEEECCSSBCHHHHHHHHHHHHHHSC---CCCCEEECTTSCCBTTH--
T ss_pred             CcceEEECCCCCCCHHHHHHHHHHHh-hCCCCCEEECcCCCcchHHHHHHHHHHhcCC---CCceEEEccCCCCcHHH--
Confidence            3577777766643 334444444443 3467777777777777777777766655321   25677777666543211  


Q ss_pred             cchHHHHHHHhCCCCCCEEEccCCCCCchHHHHHHHHhccCCCCccEEECcCCCCCCcccccccCCchhhcccCCCcCcc
Q 010572          276 SVVVELVSFLSSGRSLCSLKLRHCHLDRDFGRMVFSSLLEASSSLSILDLSGNSIGGWLSKYDRSGPLFSLGAGKSLQSL  355 (507)
Q Consensus       276 ~l~~~L~~~L~~~~sL~~L~LS~N~L~~~g~~~L~~~L~~~~~~L~~LdLS~N~L~~~l~~~~~~~l~~~L~~~~~L~~L  355 (507)
                        ...+..++..+++|++|+|++|.+++.|+..++.++.+..++|++|+|++|.|++...    ..+..++..+++|++|
T Consensus       216 --~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~----~~l~~~l~~~~~L~~L  289 (461)
T 1z7x_W          216 --CRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGC----GDLCRVLRAKESLKEL  289 (461)
T ss_dssp             --HHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHH----HHHHHHHHHCTTCCEE
T ss_pred             --HHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHH----HHHHHHHhhCCCcceE
Confidence              1235667778888888888888888888888887776667888888888888875211    1112245556666666


Q ss_pred             ccccch---hHHHHHHhhhc---CCCcEEEeccCCCCchhHHHHHHhhcCCCCCCEEeccCCCCChHHHHHHHhhCCC-C
Q 010572          356 RLLNLS---HIAASLGKFFG---TSVQVLNIGAIGLGSSGFRVLQDGVTKELKLVNINISKNRGGVETAKFLSKLMPL-A  428 (507)
Q Consensus       356 ~ll~l~---~~~~~L~~~l~---~~L~~L~Ls~n~l~~~G~~~L~~aL~~n~~L~~LdLs~N~i~~~g~~~L~~~L~~-n  428 (507)
                      .+.++.   .+...++..+.   ++|++|+|++|.+++.|+..++.++..+.+|++|+|++|.+++.++..+++++.. +
T Consensus       290 ~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~  369 (461)
T 1z7x_W          290 SLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPG  369 (461)
T ss_dssp             ECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTT
T ss_pred             ECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCC
Confidence            666654   34444544443   4666666666666666666666666666666666666666666666666665543 4


Q ss_pred             CCccEEEccCCCCChhHHHHHHHHHhcCCCCccEEEecCCCCCCCccHHHHHHHHHH
Q 010572          429 PELVEVNAGYNLMPLESLTIICSALKVAKGHLQRLDLTGNNWELQPSHVSMLSEFRH  485 (507)
Q Consensus       429 ~~L~~L~Ls~N~l~~~g~~~L~~aL~~~~~~L~~LdL~~N~~~~~~~~~~~l~~~~~  485 (507)
                      ++|++|++++|.++++|+..+..++... .+|++|+|++|.+  +..++..+.+...
T Consensus       370 ~~L~~L~L~~n~i~~~~~~~l~~~l~~~-~~L~~L~l~~N~i--~~~~~~~l~~~l~  423 (461)
T 1z7x_W          370 SVLRVLWLADCDVSDSSCSSLAATLLAN-HSLRELDLSNNCL--GDAGILQLVESVR  423 (461)
T ss_dssp             CCCCEEECTTSCCCHHHHHHHHHHHHHC-CCCCEEECCSSSC--CHHHHHHHHHHHT
T ss_pred             CceEEEECCCCCCChhhHHHHHHHHHhC-CCccEEECCCCCC--CHHHHHHHHHHhc
Confidence            4566666666666666666666666554 4566666666653  5555555544443



>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Back     alignment and structure
>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Back     alignment and structure
>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Back     alignment and structure
>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Back     alignment and structure
>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Back     alignment and structure
>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Back     alignment and structure
>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Back     alignment and structure
>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Back     alignment and structure
>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 Back     alignment and structure
>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Back     alignment and structure
>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 Back     alignment and structure
>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Back     alignment and structure
>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Back     alignment and structure
>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Back     alignment and structure
>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Back     alignment and structure
>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Back     alignment and structure
>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Back     alignment and structure
>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Back     alignment and structure
>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Back     alignment and structure
>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Back     alignment and structure
>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Back     alignment and structure
>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Back     alignment and structure
>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Back     alignment and structure
>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Back     alignment and structure
>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Back     alignment and structure
>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Back     alignment and structure
>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Back     alignment and structure
>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Back     alignment and structure
>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Back     alignment and structure
>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Back     alignment and structure
>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Back     alignment and structure
>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Back     alignment and structure
>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Back     alignment and structure
>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Back     alignment and structure
>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Back     alignment and structure
>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Back     alignment and structure
>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Back     alignment and structure
>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} Back     alignment and structure
>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Back     alignment and structure
>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Back     alignment and structure
>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Back     alignment and structure
>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Back     alignment and structure
>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Back     alignment and structure
>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Back     alignment and structure
>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Back     alignment and structure
>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} Back     alignment and structure
>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Back     alignment and structure
>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Back     alignment and structure
>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Back     alignment and structure
>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Back     alignment and structure
>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Back     alignment and structure
>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Back     alignment and structure
>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Back     alignment and structure
>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Back     alignment and structure
>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Back     alignment and structure
>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Back     alignment and structure
>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Back     alignment and structure
>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Back     alignment and structure
>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Back     alignment and structure
>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Back     alignment and structure
>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Back     alignment and structure
>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Back     alignment and structure
>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Back     alignment and structure
>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Back     alignment and structure
>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Back     alignment and structure
>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Back     alignment and structure
>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Back     alignment and structure
>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Back     alignment and structure
>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Back     alignment and structure
>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Back     alignment and structure
>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Back     alignment and structure
>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Back     alignment and structure
>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Back     alignment and structure
>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Back     alignment and structure
>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Back     alignment and structure
>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Back     alignment and structure
>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Back     alignment and structure
>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Back     alignment and structure
>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Back     alignment and structure
>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Back     alignment and structure
>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Back     alignment and structure
>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Back     alignment and structure
>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Back     alignment and structure
>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Back     alignment and structure
>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Back     alignment and structure
>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Back     alignment and structure
>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Back     alignment and structure
>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Back     alignment and structure
>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Back     alignment and structure
>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Back     alignment and structure
>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Back     alignment and structure
>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Back     alignment and structure
>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Back     alignment and structure
>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Back     alignment and structure
>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Back     alignment and structure
>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Back     alignment and structure
>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Back     alignment and structure
>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Back     alignment and structure
>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* Back     alignment and structure
>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Back     alignment and structure
>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Back     alignment and structure
>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* Back     alignment and structure
>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Back     alignment and structure
>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Back     alignment and structure
>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Back     alignment and structure
>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Back     alignment and structure
>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Back     alignment and structure
>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Back     alignment and structure
>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Back     alignment and structure
>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Back     alignment and structure
>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Back     alignment and structure
>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A Back     alignment and structure
>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Back     alignment and structure
>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Back     alignment and structure
>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Back     alignment and structure
>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} Back     alignment and structure
>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Back     alignment and structure
>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Back     alignment and structure
>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Back     alignment and structure
>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Back     alignment and structure
>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Back     alignment and structure
>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A Back     alignment and structure
>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Back     alignment and structure
>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Back     alignment and structure
>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Back     alignment and structure
>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Back     alignment and structure
>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Back     alignment and structure
>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Back     alignment and structure
>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} Back     alignment and structure
>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Back     alignment and structure
>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Back     alignment and structure
>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Back     alignment and structure
>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Back     alignment and structure
>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Back     alignment and structure
>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Back     alignment and structure
>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} Back     alignment and structure
>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Back     alignment and structure
>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A Back     alignment and structure
>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Back     alignment and structure
>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A Back     alignment and structure
>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} Back     alignment and structure
>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A Back     alignment and structure
>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A Back     alignment and structure
>4hfx_A Transcription elongation factor B polypeptide 3; structural genomics, PSI-biology, northeast structural genom consortium, NESG; 2.54A {Homo sapiens} Back     alignment and structure
>2e31_A FBS1, F-box only protein 2; ubiquitin, SCF, ubiquitin ligase, FBS1; 2.40A {Mus musculus} PDB: 2e32_A Back     alignment and structure

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query 507
d1z7xw1460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 4e-04
d1z7xw1 460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 0.003
d1z7xw1460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 0.004
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]
 Score = 40.3 bits (92), Expect = 4e-04
 Identities = 11/90 (12%), Positives = 30/90 (33%)

Query: 402 KLVNINISKNRGGVETAKFLSKLMPLAPELVEVNAGYNLMPLESLTIICSALKVAKGHLQ 461
            L  + ++       +   L+  +     L E++   N +    +  +  +++     L+
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429

Query: 462 RLDLTGNNWELQPSHVSMLSEFRHNGLPIL 491
           +L L    W  +        E     L ++
Sbjct: 430 QLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459


>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure

Homologous Domains Detected by HHsearch ?

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query507
d1z7xw1460 Ribonuclease inhibitor {Human (Homo sapiens) [TaxI 99.93
d2ca6a1344 Rna1p (RanGAP1), N-terminal domain {Fission yeast 99.92
d2ca6a1344 Rna1p (RanGAP1), N-terminal domain {Fission yeast 99.91
d1z7xw1 460 Ribonuclease inhibitor {Human (Homo sapiens) [TaxI 99.86
d1pgva_167 Tropomodulin C-terminal domain {nematode (Caenorha 99.66
d1pgva_167 Tropomodulin C-terminal domain {nematode (Caenorha 99.64
d1io0a_166 Tropomodulin C-terminal domain {Chicken (Gallus ga 99.6
d1io0a_166 Tropomodulin C-terminal domain {Chicken (Gallus ga 99.58
d1ogqa_313 Polygalacturonase inhibiting protein PGIP {Kidney 99.57
d2astb2284 Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa 99.5
d2astb2284 Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa 99.41
d1p9ag_266 von Willebrand factor binding domain of glycoprote 99.0
d1ozna_284 Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma 98.94
d1xkua_305 Decorin {Cow (Bos taurus) [TaxId: 9913]} 98.9
d2omza2384 Internalin A {Listeria monocytogenes [TaxId: 1639] 98.87
d1ogqa_313 Polygalacturonase inhibiting protein PGIP {Kidney 98.87
d2omza2384 Internalin A {Listeria monocytogenes [TaxId: 1639] 98.86
d1p9ag_266 von Willebrand factor binding domain of glycoprote 98.86
d1xkua_305 Decorin {Cow (Bos taurus) [TaxId: 9913]} 98.85
d1h6ta2210 Internalin B {Listeria monocytogenes [TaxId: 1639] 98.82
d1ozna_284 Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma 98.82
d1h6ua2227 Internalin H {Listeria monocytogenes [TaxId: 1639] 98.77
d2omxa2199 Internalin B {Listeria monocytogenes [TaxId: 1639] 98.7
d2omxa2199 Internalin B {Listeria monocytogenes [TaxId: 1639] 98.69
d1h6ua2227 Internalin H {Listeria monocytogenes [TaxId: 1639] 98.63
d1h6ta2210 Internalin B {Listeria monocytogenes [TaxId: 1639] 98.59
d1dcea3124 Rab geranylgeranyltransferase alpha-subunit, C-ter 98.53
d1dcea3124 Rab geranylgeranyltransferase alpha-subunit, C-ter 98.45
d1a9na_162 Splicesomal U2A' protein {Human (Homo sapiens) [Ta 98.41
d1w8aa_192 Slit {Fruit fly (Drosophila melanogaster) [TaxId: 98.39
d1a9na_162 Splicesomal U2A' protein {Human (Homo sapiens) [Ta 98.33
d1jl5a_353 Leucine rich effector protein YopM {Yersinia pesti 98.32
d1w8aa_192 Slit {Fruit fly (Drosophila melanogaster) [TaxId: 98.3
d1m9la_198 Outer arm dynein light chain 1 {Green algae (Chlam 98.15
d1koha1162 mRNA export factor tap {Human (Homo sapiens) [TaxI 97.77
d1m9la_198 Outer arm dynein light chain 1 {Green algae (Chlam 97.71
d1xwdc1242 Follicle-stimulating hormone receptor {Human (Homo 97.68
d1xwdc1242 Follicle-stimulating hormone receptor {Human (Homo 97.31
d2ifga3156 High affinity nerve growth factor receptor, N-term 97.3
d2ifga3156 High affinity nerve growth factor receptor, N-term 97.2
d1jl5a_ 353 Leucine rich effector protein YopM {Yersinia pesti 97.19
d1koha1162 mRNA export factor tap {Human (Homo sapiens) [TaxI 97.11
d2ovrb1102 F-box/WD repeat-containing protein 7, FBXW7 {Human 95.16
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93  E-value=9.3e-25  Score=224.42  Aligned_cols=310  Identities=16%  Similarity=0.140  Sum_probs=224.1

Q ss_pred             eeEEEEecc-Ccchhhhhhhhc-cCCcCeeeccccc-ChhhHHHHHHHHhhCCCCccEEEeecCCCChhHHHHHHHHhcc
Q 010572          175 YARCLRLQN-ALCVEETCQLLR-ESKLQSLVLRWIR-FEEHVQALCKLLIQNSETLASLEFLHCKLSPSFVEGICRSLCS  251 (507)
Q Consensus       175 ~v~~L~L~~-~l~~~~~~~ll~-~~~L~~L~Ls~~~-~~~~~~~l~~~L~~~~~~L~~LdLs~~~ls~~~~~~L~~~L~~  251 (507)
                      .+++|+++. -+....+..+++ ..++++|+|+++. ++.+++.++.++. ..++|++|||++|.+++.++..++..|..
T Consensus         3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~-~~~~L~~LdLs~N~i~~~~~~~l~~~l~~   81 (460)
T d1z7xw1           3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALR-VNPALAELNLRSNELGDVGVHCVLQGLQT   81 (460)
T ss_dssp             EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHH-TCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred             CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHh-cCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence            367777763 112222233333 5678999998775 5678888887774 56899999999999999999999998876


Q ss_pred             CCcccccccceeccccccccCCCCcchHHHHHHHhCCCCCCEEEccCCCCCchHHHHHHHHhccCC--------------
Q 010572          252 KRKRIHKIENLSIDISSFIENCPSSVVVELVSFLSSGRSLCSLKLRHCHLDRDFGRMVFSSLLEAS--------------  317 (507)
Q Consensus       252 ~~~~~~~l~~L~l~~~~~le~~~~~l~~~L~~~L~~~~sL~~L~LS~N~L~~~g~~~L~~~L~~~~--------------  317 (507)
                      ..   +.++.|+++.+.+.+..    ...+++++..+++|++|+|++|.+++.|+..+...+....              
T Consensus        82 ~~---~~L~~L~L~~n~it~~~----~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~  154 (460)
T d1z7xw1          82 PS---CKIQKLSLQNCCLTGAG----CGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLS  154 (460)
T ss_dssp             TT---CCCCEEECTTSCCBGGG----HHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCB
T ss_pred             CC---CCCCEEECCCCCccccc----cccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccc
Confidence            43   46899998877654321    1246788999999999999999999999888877664332              


Q ss_pred             --------------CCccEEECcCCCCCCcc--------ccc----------ccCC-------chhhccc----------
Q 010572          318 --------------SSLSILDLSGNSIGGWL--------SKY----------DRSG-------PLFSLGA----------  348 (507)
Q Consensus       318 --------------~~L~~LdLS~N~L~~~l--------~~~----------~~~~-------l~~~L~~----------  348 (507)
                                    ..++.++++.+.+....        ...          .+..       ....+..          
T Consensus       155 ~~~~~~~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~  234 (460)
T d1z7xw1         155 AASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALG  234 (460)
T ss_dssp             GGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECC
T ss_pred             hhhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchh
Confidence                          45666666655543100        000          0000       0000011          


Q ss_pred             -------------------CCCcCccccccch------------------------------------------------
Q 010572          349 -------------------GKSLQSLRLLNLS------------------------------------------------  361 (507)
Q Consensus       349 -------------------~~~L~~L~ll~l~------------------------------------------------  361 (507)
                                         ...++.|.+.++.                                                
T Consensus       235 ~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L  314 (460)
T d1z7xw1         235 SNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQL  314 (460)
T ss_dssp             SSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCC
T ss_pred             hccccccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhcccccccccc
Confidence                               1122222221110                                                


Q ss_pred             ------------hHHHHHHhhhc--CCCcEEEeccCCCCchhHHHHHHhhcC-CCCCCEEeccCCCCChHHHHHHHhhCC
Q 010572          362 ------------HIAASLGKFFG--TSVQVLNIGAIGLGSSGFRVLQDGVTK-ELKLVNINISKNRGGVETAKFLSKLMP  426 (507)
Q Consensus       362 ------------~~~~~L~~~l~--~~L~~L~Ls~n~l~~~G~~~L~~aL~~-n~~L~~LdLs~N~i~~~g~~~L~~~L~  426 (507)
                                  .++..++.++.  ++|++|+|++|.|+++|+..+++++.. +..|++|+|++|.|+++|+..|++++.
T Consensus       315 ~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~  394 (460)
T d1z7xw1         315 ESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLL  394 (460)
T ss_dssp             CEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHH
T ss_pred             ccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHh
Confidence                        34455555544  678999999999999999999998865 667999999999999999999999988


Q ss_pred             CCCCccEEEccCCCCChhHHHHHHHHHhcCCCCccEEEecCCCCCCCccHHHHHHHHHHcCCCeEEcC
Q 010572          427 LAPELVEVNAGYNLMPLESLTIICSALKVAKGHLQRLDLTGNNWELQPSHVSMLSEFRHNGLPILILP  494 (507)
Q Consensus       427 ~n~~L~~L~Ls~N~l~~~g~~~L~~aL~~~~~~L~~LdL~~N~~~~~~~~~~~l~~~~~~~~~i~~~~  494 (507)
                      .+++|++|+|++|.|+++|+..++++++.+.+.|+.|++.+|.+  ..+..+.+.++.++.|.|.|+.
T Consensus       395 ~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~--~~~~~~~l~~l~~~~~~l~~~~  460 (460)
T d1z7xw1         395 ANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYW--SEEMEDRLQALEKDKPSLRVIS  460 (460)
T ss_dssp             HCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCC--CHHHHHHHHHHHHHCTTSEEEC
T ss_pred             cCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCC--CHHHHHHHHHHHHhCCCCEEeC
Confidence            88999999999999999999999999998878899999999986  7788899999999999887763



>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Back     information, alignment and structure
>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} Back     information, alignment and structure
>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} Back     information, alignment and structure
>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} Back     information, alignment and structure
>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} Back     information, alignment and structure
>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Back     information, alignment and structure
>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Back     information, alignment and structure
>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Back     information, alignment and structure
>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Back     information, alignment and structure
>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Back     information, alignment and structure
>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Back     information, alignment and structure
>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Back     information, alignment and structure
>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Back     information, alignment and structure
>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Back     information, alignment and structure
>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Back     information, alignment and structure
>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Back     information, alignment and structure
>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Back     information, alignment and structure
>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d2ovrb1 a.158.1.1 (B:2263-2364) F-box/WD repeat-containing protein 7, FBXW7 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure